Pharmacology

• US Cannabis Regulation: What It Means for Naturopathic Doctors (30 Sep 2024)
  
• Cannabis and autism, explained (24 Sep 2024)
  
• MOESM4 of Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews (23 Sep 2024)
  
• Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions (23 Sep 2024)
  
• Regulation and marketing of cannabidiol-containing products in European countries. Pharmacists’ knowledge in Bulgaria (16 Sep 2024)
  
• Pharmacology and drug interactions of cannabinoids (16 Sep 2024)
  
• Epidiolex (Cannabidiol) Primer: Frequently Asked Questions for Patients and Caregivers (16 Sep 2024)
  
• Commercial Cannabidiol Caution: A New Gold Rush (16 Sep 2024)
  
• ‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology (16 Sep 2024)
  
• Cannabinoids as an Alternative Option for Conventional Analgesics in Cancer Pain Management: A Pharmacogenomics Perspective (16 Sep 2024)
  
• Adverse events following cannabis for medical use in Tuscany: An analysis of the Italian Phytovigilance database (16 Sep 2024)
  
• A Scoping Review on Clinical Trials of Pain Reduction With Cannabis Administration in Adults (16 Sep 2024)
  
• Lessons for cannabinoid regulation from electronic nicotine delivery system product regulation (03 Sep 2024)
  
• Trends in prescription and cost of Sativex, a cannabinoid-based medicine, in treating patients with multiple sclerosis in England (02 Sep 2024)
  
• Pharmacological insights emerging from the characterization of a large collection of synthetic cannabinoid receptor agonists designer drugs (02 Sep 2024)
  
• Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists (02 Sep 2024)
  
• Drug–Cannabinoid Interactions in Selected Therapeutics for Symptoms Associated with Epilepsy, Autism Spectrum Disorder, Cancer, Multiple Sclerosis, and Pain (02 Sep 2024)
  
• Cannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology (02 Sep 2024)
  
• Cannabinoid levels description in a cohort of patients with chronic and neuropathic pain treated with Cannabis decoction: A possible role of TDM (02 Sep 2024)
  
• Cannabinoid Awareness, Reporting Use to Health Care Providers, and Perceptions Regarding Safety – Pennsylvania, March 2023–April 2023 (02 Sep 2024)
  
• Editorial: Cannabinoid interactions with ion channels, receptors, and the bio-membrane (29 Aug 2024)
  
• CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure (29 Aug 2024)
  
• CANNabinoid Drug Interaction Review (CANN-DIR™) (28 Aug 2024)
  
• Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits (25 Aug 2024)
  
• A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence (25 Aug 2024)
  
• Artificial Intelligent Deep Learning Molecular Generative Modeling of Scaffold-Focused and Cannabinoid CB2 Target-Specific Small-Molecule Sublibraries (21 Aug 2024)
  
• Safety Considerations in Cannabinoid-Based Medicine (20 Aug 2024)
  
• Medicinal Cannabis and Synthetic Cannabinoid Use (20 Aug 2024)
  
• A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid (20 Aug 2024)
  
• Cannabinoid Delivery Systems for Pain and Inflammation Treatment (19 Aug 2024)
  
• Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis (24 May 2024)
  
• Exploring the topic structure and abuse trends of new psychoactive Substance since the 21st century from a bibliometric perspective (24 May 2024)
  
• CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions (24 May 2024)
  
• Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy (13 May 2024)
  
• CB2 Receptor Involvement in the Treatment of Substance Use Disorders (05 Sep 2022)
  
• Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses (01 Sep 2022)
  
• Editorial: Challenges and Conundrums in Cannabinoid-Based Treatments for Epilepsy Syndromes and Associated Neurobehavioral Comorbidities (01 Sep 2022)
  
• 1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists (27 Aug 2022)
  
• α-Glucosidase inhibitory activity of cannabidiol, tetrahydrocannabinol and standardized cannabinoid extracts from Cannabis sativa (13 Aug 2022)
  
• A Phase I Trial to Determine the Pharmacokinetics, Psychotropic Effects, and Safety Profile of a Novel Nanoparticle-Based Cannabinoid Spray for Oromucosal Delivery (07 Aug 2022)
  
• The Transdermal Delivery of Therapeutic Cannabinoids (05 Aug 2022)
  
• Pharmacokinetics of Cannabidiol Following Intranasal, Intrarectal, and Oral Administration in Healthy Dogs (31 Jul 2022)
  
• A critical review of cannabis in medicine and dentistry: A look back and the path forward (31 Jul 2022)
  
• A content analysis of internet information sources on medical cannabis - Journal of Cannabis Research (26 Jul 2022)
  
• Exploring cannabinoid bioavailability in the medical cannabis industry (25 Jul 2022)
  
• Medical Uses of CBD (21 Jul 2022)
  
• CBD User's Guide (21 Jul 2022)
  
• CBD & Its Entourage (21 Jul 2022)
  
• Cannabis and Cannabinoids (PDQ®)–Health Professional Version (21 Jul 2022)
  
• Cannabis and Cancer, Part 1: Despite Lack of Evidence, Cannabis Products Being Widely Used (21 Jul 2022)
  
• What is CBD? Definition of Cannabidiol & CBD Oil (20 Jul 2022)
  
• Single Compound vs. Whole Plant CBD (20 Jul 2022)
  
• How to use CBD & Cannabis (20 Jul 2022)
  
• CBIS Cannabinoid Research (20 Jul 2022)
  
• Cannabis Therapy for Seizures in Animals (20 Jul 2022)
  
• What Is HHC? (18 Jul 2022)
  
• What is Cannabichromene (CBC)? Benefits, Uses, Dosages (18 Jul 2022)
  
• Very high doses of CBD, a cannabis component, don’t affect driving (18 Jul 2022)
  
• Top Delta-8 THC Questions Answered by CBD Science (18 Jul 2022)
  
• Top CBN (Cannabinol) Questions Answered by CBD Science (18 Jul 2022)
  
• Top CBL Questions Answered by CBD Science (18 Jul 2022)
  
• Top CBDA (Cannabidiolic Acid) Questions Answered by CBD Science (18 Jul 2022)
  
• Top CBD (Cannabidiol) Questions Answered by CBD Science (18 Jul 2022)
  
• Tablet containing CBD shows promise in reducing post-operative pain (18 Jul 2022)
  
• Study provides insights on the effects of cannabidiol on severe form of epilepsy (18 Jul 2022)
  
• Some cannabis products associated with short-term chronic pain improvements, but side effects a concern (18 Jul 2022)
  
• Prescribed CBD could help people quit cannabis (18 Jul 2022)
  
• Pharma aims to make a better CBD (18 Jul 2022)
  
• New study: Cannabis helps fight resistant bacteria (18 Jul 2022)
  
• Here’s the truth about CBD, from a cannabis researcher (18 Jul 2022)
  
• Epileptic seizure frequency fell by 86% in kids treated with whole plant medicinal cannabis (18 Jul 2022)
  
• Cresco Labs (18 Jul 2022)
  
• CBD shows promise for fighting aggressive brain cancer (18 Jul 2022)
  
• CBD and THC are Safe Supplements to Opioid Treatment (18 Jul 2022)
  
• Cannabis-Derived Lignanamides: Potential Candidates for the Treatment of Multidrug-Resistant Cancers (18 Jul 2022)
  
• Cannabidiol (CBD) in cannabis does not impair driving, landmark study shows (18 Jul 2022)
  
• Animal study shows safety of using CBD and THC with opioids (18 Jul 2022)
  
• 10 CBD facts every user should know (18 Jul 2022)